Open retropubic radical prostatectomy versus external beam radiation therapy for localized prostate cancer - patient-reported outcomes
Open Access
- 1 January 2023
- journal article
- research article
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 151 (11-12) , 658-664
Abstract
Introduction/Objective. Active treatment options for localized prostate cancer (LPCa) include surgery and radiotherapy with androgen deprivation therapy (ADT) in selected cases, but all options have side effects, mainly addressed to urinary, sexual and bowel function. Our study aimed to assess and compare patient-reported outcome measures (PROMs) after retropubic radical prostatectomy (ORRP) or external beam radiotherapy (EBRT). Methods. Between June 2019 and May 2021, a total of 120 patients, with LPCa had undergone active treatment, as follow: open retropubic radical prostatectomy (ORRP) - 60 patients and external beam radiotherapy (EBRT) - 60 patients. A validated questionnaire, the Expanded Prostate Cancer Index Composite Short Form (EPIC-26) instrument was used to assess PROM, through the following domains: urinary, sexual and bowel. Patients completed a questionnaire at baseline and six, 12 and 24 months after primary treatment. Results. All urinary scores had statistically significant time x group interaction. After six, 12 and 24 months, all urinary scores were statistically significantly lower in the ORRP group. After 12 and 24 months, bowel score values were statistically significantly lower in patients in the ERBT group. Sexual scores change statistically significant during the follow-up period, without difference between the groups (p < 0.05). Conclusion. both ORRP and EBRT are associated with decline of sexual scores. ORRP showed significant variations in all urinary scores, with more pronounced negative impact on urinary symptoms compared to EBRT during the entire follow-up period. Bowel scores are lower in EBRT.Keywords
This publication has 18 references indexed in Scilit:
- Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJAMA, 2020
- Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2020
- Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapyJapanese Journal of Clinical Oncology, 2019
- Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewEuropean Urology, 2017
- Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsJAMA, 2017
- Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate CancerJAMA, 2017
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2016
- Patient reported outcome measures could help transform healthcareBMJ, 2013
- Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer SurvivorsUrology, 2010
- ANATOMIC RADICAL PROSTATECTOMYJournal of Urology, 1998